Document:

Agreement between Noble International Ltd and Thomas L. Saeli

 Exhibit 10.1 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made this 8th
day of May, 2006, and effective as of March 1, 2006 (the “Effective Date”) by and between Thomas L. Saeli (“Employee”) and Noble International, Ltd, a Delaware corporation, whose address is 28213 Van Dyke Avenue, Warren,
Michigan 48093 (the “Company”). 
 RECITALS 
 WHEREAS, the Company is engaged in the business of laser blank welding for the automotive industry (the “Business”). 
 WHEREAS, the Company desires to employ Employee as its Chief Executive Officer, and Employee desires to be employed by the Company, upon the terms and conditions set forth in this Agreement. 
 NOW, THEREFORE, in consideration of the mutual covenants and obligations contained herein, and intending to be legally bound, the parties, subject
to the terms and conditions set forth herein, agree as follows: 
 TERMS 
 1. Employment Term. Subject to the terms and conditions set forth herein, the Company agrees to employ Employee, and Employee hereby accepts
employment, as the Chief Executive Officer (“CEO”) of the Company and its subsidiaries (the “Position”), for a term commencing on March 1, 2006 (the “Commencement Date”) and ending on December 31, 2008 (the
“Employment Term”) unless otherwise terminated under this Agreement. The Employment Term will automatically extend for successive periods of one year at the end of the then current Employment Term unless either the Company or
Employee notifies the other in writing (a “Non-Renewal Notice”) of the expiration of the Employment Term at least 90 days prior to the end of the then current Employment Term. Employee and the Company agree that Employee’s
employment with the Company constitutes “at-will” employment. Employee and the Company acknowledge that this employment relationship may be terminated at any time, upon written notice to the other party, with or without good cause or for
any or no cause, at the option either of the Company or Employee. However, as described in this Agreement, Employee may be entitled to severance benefits depending upon the circumstances of Employee’s termination of employment. 
 2. Duties. During the Term, Employee shall serve the Company faithfully and to the best of Employee’s ability, shall devote Employee’s
full attention, skill and efforts to the performance of the duties of the Position. Employee shall report to the Company’s Board of Directors. Employee will render such business and professional services in the performance of his duties,
consistent with Employee’s position within the Company, as will reasonably be assigned to him by the Board. During the Employment Term, Employee will devote Employee’s full business efforts and time to the Company and will use good faith
efforts to discharge Employee’s obligations under this Agreement to the best of Employee’s ability. For the duration of the Employment Term, Employee agrees not to actively engage in any other employment, 

 occupation, or consulting activity for any direct or indirect remuneration without the prior approval of the Board (which
approval will not be unreasonably withheld); provided, however that Employee may, without the approval of the Board, serve in any capacity with any civic, educational, or charitable organization, provided such services do not interfere with
Employee’s obligations to Company. 
 3. Other Business Activities. During the Employment Term, other than as provided in
Section 2 above, Employee will not engage in any other business activities or pursuits which are contrary to Employee’s responsibilities and obligations pursuant to this Agreement. 
 4. Compensation. 
  

	 	a.	Base Salary. As of the Effective Date, the Company will pay Employee an annual salary of $500,000 as compensation for his services (such annual salary, as is then effective,
to be referred to herein as “Base Salary”). The Base Salary will be paid periodically in accordance with the Company’s normal payroll practices and be subject to the usual, required withholdings. Employee’s salary will be subject
to review by the Compensation Committee of the Board, or any successor thereto (the “Committee”) not less than annually, and adjustments may be made at the discretion of the Committee. Notwithstanding the foregoing, the Base Salary will
not be reduced other than pursuant to a reduction that also is applied to substantially all other executive officers of the Company and that reduces the Base Salary by a portion that is substantially proportional to other executive officers.

  

	 	b.	Annual Incentive. Employee will be eligible to receive annual cash incentives payable for the achievement of performance totals established by the Committee. The actual
earned annual cash incentive, if any, payable to Employee for any performance period will depend upon the extent to which the applicable performance goal(s) specified by the Committee are achieved and will be decreased or increased accordingly. For
calendar year 2006 only, Employee will receive a guaranteed bonus of $250,000, payable in the first quarter of 2007. All payment of Annual Incentive shall be subject to normal and customary withholdings. 

  

	 	c.	Restricted Stock Grant. Employee will be granted $250,000 worth of shares of restricted common stock of the Company, based upon the closing price of the stock on the day
immediately preceding his first day of employment with the Company (the “Stock Grant”). The Stock Grant will be issued under the terms of the Company’s 2001 Employee Stock Incentive Plan and will bear a restriction prohibiting the
Employee from trading such shares during the initial Employment Term. 

  

 2 

	 	d.	Long-Term Incentive. 

 i. Upon
commencement of Employees employment with the Company he shall, in connection with this Agreement, be granted up to 400,000 stock appreciation right (“SAR”) units under the Noble International Ltd 2006 Stock Appreciation Rights Plan (the
“Plan”), as follows: 
 (1) 150,000 Units upon commencement of employment with the Company at the closing price of
the stock on the date immediately prior to Commencement Date; 
 (2) 50,000 Units upon the stock reaching a closing price of
$16.75 
 (3) 50,000 Units upon the stock reaching a closing price of $17.50 
 (4) 25,000 Units upon the stock reaching a closing price of $18.25 
 (5) 25,000 Units upon the stock reaching a closing price of $18.25 
 (6) 50,000 Units upon the stock reaching a closing price of $19.00 
 (7) 50,000 Units upon the stock reaching a closing price of $19.75 
 ii. For purpose of the grants under this section 4d(i)(5-7), the closing price will be deemed to be achieved only when the average closing
price of the Company’s stock achieves the designated closing price during five (5) out of twenty five (25) consecutive trading days. 
 iii. The achievement of the closing price target set forth in 4(d)(1-7) and commencement of the grant period will be acknowledged in writing by the Company’s General Counsel. 
 iv. The SAR Units received hereunder shall vest in equal annual increments over a four (4) year period from the date of the grant and
shall be subject to the general terms and conditions of the SAR Unit Agreement provided under the Plan. 
 v. The terms and
language of this document will control any conflicts between the SAR Appreciation Rights Plan or the SAR Unit Agreement and this Agreement. 
 5. Benefits. Employee shall be entitled to those employee benefits which the Company from time to time generally make available to employees and/or Employees (“Benefits”) pursuant to the terms and conditions of the
Company’s benefit plans and/or policies. The Benefits shall initially include, without limitation: 
 a. Medical, dental, vision, and
life and disability insurance and such other benefits as the Company may determine from time to time. 
  

 3 

 b. Incentive, savings and retirement plans, practices, policies and programs applicable to Employees of
the Company, including 401(k), and stock matching. 
 c. Paid vacation time in accordance with the plans, practices, policies and programs
applicable to Employees of the Company at four weeks for each calendar year. 
 d. Monthly reimbursement of any country club and/or private
club dues incurred by him. 
 6. Reimbursement of Business Expenses. Subject to such conditions as the Company may from time to time
determine, Employee shall be reimbursed for ordinary and reasonable documented expenses incurred by Employee in the performance of Employee’s duties under this Agreement. In addition, Employee shall be entitled to an automobile expense in the
amount of One Thousand Five Hundred Dollars ($1,500) per month plus a Company paid gas card. Employee shall also be reimbursed for cellular telephone and personal data assistant costs and expenses as well as customary expenses relating to
professional activities. 
 7. Confidentiality. Employee recognizes and acknowledges that the Confidential Information (as hereinafter
defined) is a valuable, special and unique asset of the Company. As a result, both during the Term and for a period the greater of two years or when Employee no longer received compensation or Severance hereunder, Employee shall not, without the
prior written consent of the Company, for any reason, either directly or indirectly divulge to any third party or use for Employee’s own benefit or for any purpose other than the exclusive benefit of the Company any confidential, proprietary,
business or technical information or trade secrets of the Company or of any subsidiary or affiliate of the Company (“Confidential Information”) revealed, obtained or developed in the course of Employee’s employment with the Company.
Such Confidential Information shall include, but shall not be limited to, the intangible personal property described in Section 8.b hereof, any information relating to methods of production, manufacture, service, research, specifications,
computer codes, business, marketing and sales techniques and concepts, other data and materials used in performing the Employee’s duties (other than his personal contact list), costs, business studies, finances, marketing data, plans and
efforts, the terms of contracts and agreements with customers, contractors and suppliers, litigation strategy and other Confidential Information relating to litigation, the Company’s relationship with actual and prospective customers,
contractors and suppliers and the needs and requirements of, and the Company’s course of dealing with, any such actual or prospective customers, contractors and suppliers, personnel information, and any other materials that have not been made
available to the industry; provided, that nothing herein contained shall restrict Employee’s ability to make such disclosures during the course of Employee’s employment as may be necessary or appropriate to the effective and efficient
discharge of the duties required by or appropriate for Employee’s Position or as such disclosures may be required by law; and 
  

 4 

 further provided, that nothing herein contained shall restrict Employee from divulging or using for Employee’s own
benefit or for any other purpose any Confidential Information that is readily available to the general public so long as such information did not become available to the general public as a direct or indirect result of Employee’s breach of this
Section 7. 
 8. Inventions and Property. 
 a. Title to Proprietary Information. All right, title and interest in and to proprietary information shall be and remain the sole and exclusive property of the Company. During the Term, Employee shall not
remove from the Company’s offices or premises any documents, records, notebooks, files, correspondence, reports, memoranda or similar materials of, or containing, proprietary or Confidential Information or other materials or property of any
kind belonging to the Company, unless necessary or appropriate in accordance with the duties and responsibilities required by or appropriate for Employee’s position, and, in the event that such materials or property are removed, all of the
foregoing shall be returned to their proper files or places of safekeeping as promptly as possible after the removal. 
 b. Development of
Intellectual Property. 
 i. Employee agrees that all right, title and interest in and to any innovations, designs,
systems, analyses, ideas for sales and marketing programs, customer contacts, and all copyrights, patents, trademarks and trade names, or similar intangible personal property which have been or are developed or created in whole or in part by
Employee (A) at any time and at any place during Employee’s employment with the Company and which, in the case of any or all of the foregoing, are related to and used in connection with the Business or any other business of the Company,
(B) as a result of tasks assigned to Employee by the Company or (C) from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company (collectively, the “Intellectual
Property”), shall be and remain forever the sole and exclusive property of the Company. Employee shall promptly disclose to the Company all Intellectual Property and Employee shall have no claim for additional compensation for the Intellectual
Property. 
 ii. Employee acknowledges that all the Intellectual Property that is copyrightable shall be considered a work
made for hire under United States Copyright Law. To the extent that any copyrightable Intellectual Property may not be considered a work made for hire under the applicable provisions of the United States Copyright Law, or to the extent that,
notwithstanding the foregoing provisions, Employee may retain an interest in any Intellectual Property that is not copyrightable, Employee hereby irrevocably assigns and transfers to the Company any and all right, title, or interest that Employee
may have in the Intellectual Property under copyright, patent, trade secret and trademark law, in perpetuity or for the longest period otherwise permitted by law, without the necessity of further consideration. The Company shall be entitled to
obtain and hold in their own name all copyrights, patents, trade secrets, and trademarks with respect thereto. 
  

 5 

 iii. Employee further agrees to reveal promptly all information relating to the same to
an appropriate officer of the Company and to cooperate with the Company and execute such documents as may be necessary or appropriate (A) in the event that the Company desires to seek copyright, patent or trademark protection, or other
analogous protection, thereafter relating to the Intellectual Property, and when such protection is obtained, to renew and restore the same, and (B) to defend any opposition proceedings in respect of obtaining and maintaining such copyright,
patent or trademark protection, or other analogous protection. 
 9. Non-Competition 
 a. Employee agrees that the Employee shall not during the Employee’s employment with the Company, and, if the Employee’s employment is
terminated for any reason other than termination of employment without Just Cause or for Good Reason, thereafter for a period of one (1) year, directly or indirectly, engage in or become employed by any Prohibited Business as defined below.

 b. The Employee agrees that if the Employee’s employment is terminated without Just Cause (as defined in Section 10.1 hereof) or
for Good Reason (as defined in Section 10.b hereof), thereafter during the period in which the Employee is receiving payments under either Section 10.d or 10.e hereof, directly or indirectly, Employee shall not in any capacity, engage or
participate in or become employed by or render advisory or consulting or other services in connection with any Prohibited Business as defined below. 
 c. Notwithstanding Section 9.b. above, at any time during which the Employee is receiving the payments and benefits due the Employee pursuant to Sections 10.d or 10.e, as the case may be, the Employee may elect
by written notice to the Company to forego and release the Company from paying such payments and providing such benefits. From and after the date of such notice (i) the Company shall have no further obligation to make such payments or provide
such benefits, and (ii) the obligation of the Employee set forth in Section 9.a. or 9.b., as applicable. shall terminate. 
 d. The
Employee agrees that the Employee shall not during the Employee’s employment with the Company, and, if the Employee’s employment is terminated for any reason, thereafter for a period of one (1) year, make any financial investment,
whether in the form of equity or debt, or own any interest, directly or indirectly, in any Prohibited Business. Nothing in this Section 9 shall, however, restrict the Employee from making any investment in any Company whose stock is listed on a
national securities exchange or actively traded in the over-the-counter market; provided that (i) such investment does not give the Employee the right or ability to control the policy decisions of any Prohibited Business, and (ii) such
investment does not create a conflict of interest between the Employee’s duties hereunder and the Employee’s interest in such investment. 
 e. “Prohibited Business” shall be defined as any business and any branch, office or operation thereof, which is a primary competitor of the Company with respect to the Business wherever the Company does business, in North America
or abroad. 
  

 6 

 10. Termination. 
 a. Employee’s employment with the Company: (i) shall terminate upon Employee’s resignation (with or without Good Reason), death or Permanent Disability (as defined below) (each, an “Employee
Termination”); and (ii) subject to the conditions set forth below, may be terminated at any time by the Company for any reason (or no reason), including, without limitation, for Just Cause (as herein defined). In addition, if a Non-Renewal
Notice is delivered pursuant to Section 1, Employee’s employment with the Company shall terminate on the last day of the then current Employment Term and the Employment Term shall be deemed to have expired. Termination of Employee’s
employment with the Company shall be effective on the following date: (1) if terminated as a result of Employee’s resignation, on the date specified in a written notice delivered by Employee to the Company, which date shall be at least 15
days following the date of such written notice; (2) if terminated as a result of death or Permanent Disability, upon the date of such event; (3) if terminated by the Company, on the date specified in a written notice delivered by the
Company to Employee, and (4) if terminated by either the Company or Employee by virtue of delivery of a Non-Renewal Notice, on the last day of the then current Employment Term. 
 As used in this Agreement, “Just Cause” means: (i) Employee’s admission of, or conviction of any act of fraud, embezzlement or theft against the Company or any of its subsidiaries;
(ii) Employee’s plea of guilty or of no contest with respect to, admission of, or conviction for, a felony or any crime involving moral turpitude, fraud, embezzlement, theft or misappropriation; (iii) Employee’s violation of the
provisions set forth in Sections 7, 8 or 9; (iv) Employee’s misappropriation of the Company’s or any of its subsidiaries’ funds or a corporate opportunity by Employee; (v) Employee’s gross negligence, willful or
reckless conduct that has brought or is reasonably likely to bring the Company or any of its subsidiaries into public disgrace or disrepute or which has had or is reasonably likely to have a materially adverse effect on the Business; (vi) any
violation by Employee of any statutory or common law duty of loyalty to the Company or any of its subsidiaries; (vii) alcohol or substance abuse by Employee that interferes with the performance of Employee’s duties; or (viii) any
other material breach by Employee of this Agreement; provided that the reasons described in clauses (iii), (vi), (vii) and (viii) shall constitute Just Cause only upon Employee’s failure to correct such behavior prospectively
within ten (10) days following written notice thereof from, or on behalf of the independent members of the Board of Directors of the Company and provided further that “Just Cause” shall not include (1) bad judgment
or negligence other than habitual neglect of duty, (2) any act or omission believed by the Employee in good faith to have been in or not opposed to the interest of the Company (without intent of the Employee to gain therefrom, directly or
indirectly, a profit to which the Employee was not legally entitled); or (3) any act or omission with respect to which a determination could properly have been made that the Employee met the applicable standard of conduct for indemnification or
reimbursement under the by-laws of the Company, any applicable indemnification agreement or the laws and regulations under which the Company is governed, in each case in effect at the time of such act or omission. The exercise of the right of the
Company to terminate Employee’s employment for Just Cause shall not abrogate any rights or remedies of the Company in respect of the action giving rise to such termination. 
  

 7 

 b. For purposes of this Agreement, “Good Reason” shall mean (i) a reduction in the
Employee’s Base Salary, (except as otherwise provided herein) the failure to receive benefits (including Benefits) that are substantially comparable in the aggregate to those which the Employee received at the time of the signing of this
Agreement or the failure to participate in a bonus or incentive program that is substantially similar to the bonus or incentive program in which Employees of the Company participate in at the time of the signing of and during the course of this
Agreement, (ii) a substantial diminution of the Employee’s responsibilities or authority from those which would be consistent with the Employee’s position under this Agreement or such other position of the Employee as agreed in
writing by the Employee and the Company, including without limitation a change in the duties or responsibilities of Employee that are not consistent with the position of Chief Executive Officer, (iii) the Employee’s work location is
relocated more than 40 miles from his current work location, (iv) a material breach of any provision of this Agreement by the Company, in each case if the relevant circumstances or conditions are not cured (to the extent susceptible to cure) by
the Company within 30 days after receipt by the Company of written notice thereof from the Employee, and/or (v) any other material adverse change to the terms and conditions of Employee’s employment under this Agreement. 
 c. For purposes of this Agreement, “Change of Control” shall mean any of the following: (i) the sale or other transfer of more than 50% of
the ownership interests of the Company to one or more non-affiliated corporations, persons or other entities, (ii) the merger or consolidation of the Company with another non-affiliated corporation, person or entity such that the shareholders
of the Company, immediately preceding the merger or consolidation own less than 50% of the person or other entity surviving the merger or consolidation, (iii) the failure of the Company to assign this Agreement to a successor, (iv) a
majority of the members of the Board of Directors of the Company on the date of this Agreement (each a “Current Director”) cease to be members of the Board of Directors of the Company, provided that for purposes of this Section 10.c.
any director recommended by a majority of the Current Directors as a successor of a Current Directoror shall be deemed to be a Current Director, (v) any filing of voluntary or involuntary bankruptcy of the Company or agreement by the Company to
any plan of reorganization, or if the shareholders of the Company approve any plan or proposal for the liquidation or dissolution of the Company, and/or (vi) the sale, merger or other transfer of all or substantially all of the Company’s
consolidated assets to one or more non-affiliated corporations, persons or other entities. 
 d. If Employee’s employment with the
Company is terminated, voluntarily or involuntarily, within six (6) months of a Change in Control, Employee shall be entitled to, in addition to prompt payment of any salary earned prior to or on the date of termination but unpaid as of the
date of termination, (i) twenty-four months of his monthly Base Salary from the date of termination, (ii) health plan coverage provided by the Company and with respect to the Company’s welfare benefit plans, (iii) continuation of
perquisites provided for in Section 5 and (d), (iv) payment of the full value of any then vested and unvested SARs and acceleration of all SARs provided for hereunder which have not been granted, but which Employee is eligible to receive,
and (v) reimbursement of any unpaid expense Employee is otherwise entitled pursuant to Section 6. 
  

 8 

 e. If Employee’s employment with the Company is terminated prior to December 31, 2007 either
(1) by the Company without Just Cause, or (2) by the Employee for Good Reason, Employee shall be entitled to, (i) payment of his monthly Base Salary from the date of termination through December 31, 2008 and (ii) health plan
coverage provided by the Company and with respect to the Company’s welfare benefit plans through December 31, 2008, and (iv) payment of the full value of any then vested SARs (provided that notwithstanding the continuation of payments
hereunder, Employee will not be eligible to receive any future SARs or become eligible to received granted, but unvested SARs), and (iv) continuation of perquisites provided for in Section 5 (a) and (d), and (v) reimbursement of
any unpaid expense Employee is otherwise entitled pursuant to Section 6. 
 f. If Employee’s employment with the Company is
terminated after December 31, 2007 either (1) by the Company without Just Cause, (2) by the Employee for Good Reason, Employee shall be entitled to, (i) twelve (12) months of his monthly Base Salary from the date of
termination, and (ii) health plan continuation coverage (i.e. COBRA) provided by the Company and with respect to the Company’s welfare benefit plans, and (iv) payment of the full value of any then vested SARs, and
(iv) continuation of perquisites provided for in Section 5 (a) and (d), and (v) reimbursement of any unpaid expense Employee is otherwise entitled pursuant to Section 6. 
 g. If Employee’s employment with the Company is terminated for Just Cause by the Company, then, (i) all further vesting of Employee’s SARs
will terminate immediately, (ii) all payments of compensation by the Company to Employee hereunder will terminate immediately, and (iii) except for those statutorily mandated obligations of Company, all perquisites and benefits will
immediately cease. 
 h. If after December 31, 2008, Employee’s employment with the Company is terminated (1) by the Company
without Just Cause, (2) by the Employee for Good Reason, or (3) by the Company through expiration via a Non-Renewal Notice, payments of severance pay pursuant to this Section 10 shall be made in the same manner and at the same times
as payments would have been made in accordance with Section 10(f). Payments of the total amount due pursuant to payments of vested SARs shall be made in lump sum by the Company within 30 days of the date of termination, provided that the other
benefits payable to Employee shall continue for the full severance term. 
 i. If Employee’s employment by the Company is terminated by
resignation of Employee without Good Reason (other than in connection with a Change of Control pursuant to Section 10(d), Employee shall be entitled only to (i) his Base Salary accrued to the effective date of such termination, plus
(ii) pay for vacation accrued but unused as of the effective date of such termination, plus (iii) any unpaid expense reimbursement Employee is entitled to pursuant to Section 6. 
 j. In addition to any amounts or benefits provided upon termination of employment hereunder and except as otherwise provided herein, the Employee shall
be entitled to any payments or benefits explicitly provided under the terms of any plan, policy or program of the Company or as otherwise required by applicable law. 
  

 9 

 k. For the purposes of this Agreement, Employee will be deemed to be Permanently Disabled upon the
earlier of (i) the end of a six (6) consecutive month period during which, by reason of physical or mental injury or disease, the Employee has been unable to perform substantially all of his usual and customary duties under this Agreement
or (ii) the date that a reputable physician selected by the Board, and as to whom the Employee has no reasonable objection, (or pending Employee’s inability to make such determination, a reputable physician selected by the Board)
determines in writing that the Employee will, by reason of physical or mental injury or disease, be unable to perform substantially all of the Employee’s usual and customary duties under this Agreement for a period of at least six
(6) consecutive months (each a “Disability Event”). If any question arises as to whether the Employee is disabled, upon reasonable request therefore by the Board, the Employee shall submit to reasonable medical examination for the
purpose of determining the existence, nature and extent of any such disability. The Board shall promptly give the Employee written notice of any such determination of the Employee’s disability and of any decision of the Board to terminate the
Employee’s employment by reason thereof. Upon a Disability Event, Employee’s employment with the Company shall be deemed terminated, and Employee shall be entitled to, (i) twelve (12) months of his monthly Base Salary from the
date of termination, and (ii) health plan continuation coverage (i.e. COBRA) provided by the Company and with respect to the Company’s welfare benefit plans, and (iv) payment of the full value of any then vested SARs, and
(iv) continuation of perquisites provided for in Section 5 (a) and (d), and (v) reimbursement of any unpaid expense Employee is otherwise entitled pursuant to Section 6. Base salary payable to the Employee shall be reduced
dollar-for-dollar by the amount of disability benefits paid to the Employee in accordance with any disability policy or program of the Company. 
 11. Conditions to Receipt of Severance; No duty to mitigate . 
  

	 	a.	Nondisparagment. The parties agree to act hereafter in a professional and non-retaliatory manner, refraining from making disparaging remarks, innuendos, gestures,
insinuations, actions, or other verbal, nonverbal, written, electronic or other similar such expression concerning each other. The parties acknowledge that a breach or threatened breach of this provision will result in the Company suffering
irreparable harm that cannot be calculated or fully or adequately compensated by recovery of damages alone. Accordingly, the parties are entitled to equitable relief, including interim or permanent injunctive relief, specific performance, or other
equitable remedies in the event of any breach of this or any of the other of the provisions of this agreement, in addition to all other remedies which may be available to the parties, including discontinuation of the payments provided for hereunder.

  

	 	b.	Other Requirements. Employee’s receipt of continued severance payments will be subject to Employee continuing to comply with the terms of the Confidential Information
provisions of this Agreement. 

  

	 	c.	No duty to Mitigate. Except for perquisites and health care benefits, Employee will not be required to mitigate the amount of any payment contemplated by this Agreement, nor
will any earnings that Employee may receive from any other source reduce any such payment. 

  

 10 

 12. Indemnification. The Company shall indemnify Employee, to the maximum extent permitted by law,
during and after the termination of the Employee’s employment, against any and all judgments, settlement payments, costs, attorney fees, and other reasonable expenses incurred by Employee in connection with the defense of any claim, action,
suit or proceeding, arising from events before or during the term of Employee’s employment to which Employee has been made a party because the performance of employment duties under this Agreement, or by way of inclusion, the execution of this
Agreement. This right to indemnification shall be in addition to any rights that the Employee may otherwise be entitled to under the Certificate of Incorporation or Bylaws of the Company as applicable. 
 13. Survival of Provisions. The provisions of this Agreement set forth in Sections 7, 8, 9, 10, 11, 12 and 20 hereof shall survive the termination
of Employee’s employment hereunder. 
 14. Successors and Assigns. This Agreement shall inure to the benefit of and be binding
upon the Company’s successors and assigns. This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors, and legal representatives of Employee upon Employee’s death, and (b) any successor of the
Company. Any such successor of the Company will be deemed substituted for the Company under the terms of this Agreement for all purposes and the Company shall use its best efforts that any successor assumes this Contract. For this purpose,
“successor” means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly acquires all or substantially all of the assets or business of the Company. None
of the rights of Employee to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance, or other
disposition of Employee’s right to compensation or other benefits will be null and void. 
 15. Legal and Tax Expenses. The
Company will reimburse Employee for reasonable legal and tax advice expenses incurred by him in connection with the negotiation, preparation, and execution of this Agreement. In addition, in the event of a dispute relating to any provision of this
Agreement, following the Effective Date, the Company will reimburse Employee’s fees and expenses as incurred quarterly, including reasonable attorneys’ fees, in connection with such dispute, provided Employee prevails on at least one
material issue in such dispute, or provided an arbitrator does not determine that Employee’s legal positions were frivolous or without legal foundation. In the event Employee does not so prevail or in the event of such determination, Employee
will repay the Company any amounts previously reimbursed by it, and Employee will reimburse the Company for its fees and expenses, including reasonable attorneys’ fees, incurred in connection with the dispute. 
  

 11 

 16. Notice. Any notice or communication required or permitted under this Agreement shall be made
in writing and sent by certified or registered mail, return receipt requested, addressed as follows: 
 If to Employee:

 Thomas L. Saeli 
 1095 Willow Lane 
 Birmingham, MI 48009 
 If to the Company: 
 Chairman of the Compensation Commitee 
 c/o Corporate Secretary 
 28213 Van Dyke Avenue 
 Warren, MI 48093 
 or to such other address as either party may from time to time duly specify by notice given to the other party in the manner
specified above. 
 17. Entire Agreement; Amendments. This Agreement contains the entire agreement and understanding of the parties
hereto relating to the subject matter hereof, and supersedes all prior and contemporaneous discussions, agreements and understandings of every nature between the parties hereto relating to the employment of Employee with the Company. This Agreement
may not be changed or modified, except by an Agreement in writing signed by each of the parties hereto. 
 18. Waiver. The waiver of
the breach of any term or provision of this Agreement shall not operate as or be construed to be a waiver of any other or subsequent breach of this Agreement. 
 19. Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the State of Michigan without giving effect to the choice of law principles of such state. 
 20. Settlement of Disputes. Any claims, controversies, demands, disputes, or differences between the parties hereto arising out of, or by virtue
of, or in connection with, or relating to this Agreement, Employee’s employment relationship with the Company or termination of such employment relationship shall be submitted to and settled by arbitration in Southfield, Michigan before a
single arbitrator who shall be knowledgeable in the field of business law and employment relations and such arbitration shall be in accordance with the American Arbitration Association’s National Rules for Resolution of Employment Disputes then
in force. The parties agree to bear joint and equal responsibility for all fees of the arbitrator, abide by any decision rendered as final and binding, and waive the right to submit the dispute to a public tribunal for a jury or non-jury trial.

 21. Severability. In case any one or more of the provisions contained in this Agreement shall, for any reason, be held to be
invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the validity of any other provision of this Agreement, and such provision(s) shall be deemed modified to the extent necessary to make
it enforceable. 
  

 12 

 22. Section Headings. The section headings in this Agreement are for convenience only, and form no
part of this Agreement and shall not affect its interpretation. 
 23. Specific Enforcement: Extension of Period. Employee
acknowledges that the restrictions contained in Sections 7, 8 and 9 hereof are reasonable and necessary to protect the legitimate interests of the Company and its affiliates and that the Company would not have entered into this Agreement in the
absence of such restrictions. Employee also acknowledges that any breach by Employee of Sections 7, 8 and 9 hereof will cause continuing and irreparable injury to the Company for which monetary damages would not be an adequate remedy. The Employee
shall not, in any action or proceeding to enforce any of the provisions of this Agreement, assert the claim or defense that an adequate remedy at law exists. In the event of such breach by Employee, the Company shall have the right to enforce the
provisions of Sections 7, 8 and 9 of this Agreement through securing injunctive or other relief in any court without the necessity of posting a bond, and this Agreement shall not in any way limit remedies of law or in equity otherwise available to
the Company. If an action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to recover, in addition to any other relief, reasonable attorneys’ fees, costs and
disbursements. 
 24. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an
original, and all of which together shall be deemed to be one and the same instrument. 
 IN WITNESS WHEREOF, the parties have caused this
Agreement to be executed the day and year first written above. 
  

			
	“EMPLOYEE”
	
	THOMAS L. SAELI
	
	  

		
	Date:	 	  

	
	“COMPANY”
	
	NOBLE INTERNATIONAL, LTD.
	
	  

	Title:	 	  

	Date:	 	  

  

 13Amendment No. 1 to Distribution Agreement

 Exhibit 10.1 
 Portions of this Exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 406 under the
Securities Act of 1933. Such omissions are designated as ***. 
 AMENDMENT NO. 1 TO DISTRIBUTION AGREEMENT 
 This Amendment No. 1 to Distribution Agreement (this “Amendment”), dated as of February 10, 2006, is between OraSure Technologies,
Inc., a Delaware corporation (“OSUR”), and Medtech Holdings, Inc. (“Medtech Holdings”) and Medtech Products, Inc. (“Medtech Products”), each of which are Delaware corporations and wholly-owned subsidiaries of Prestige
Brands Holdings, Inc. (Medtech Products, as the assignee of Medtech Holdings hereunder, is referred to as “Distributor”). 
 BACKGROUND 
 OSUR and Distributor previously entered into that certain Distribution Agreement, dated as of
April 24, 2003 (the “Original Agreement”), pursuant to which OSUR agreed to manufacture and supply the Original Product (as defined below) for distribution by the Distributor into the OTC Market in the Territory. Capitalized terms not
otherwise defined in this Amendment shall have the meanings set forth in the Original Agreement. The parties desire to amend the Original Agreement in order to provide for (i) the assignment of the Original Agreement as amended hereby by
Medtech Holdings to Medtech Products and (ii) the distribution of a new promotional product into the OTC Market in the Territory, pursuant to the terms set forth in the Original Agreement as amended by this Amendment. 
 AGREEMENT 
 NOW, THEREFORE, in
consideration of the foregoing, and the other mutual promises and covenants contained in this Amendment, OSUR and Distributor, intending to be legally bound, hereby agree as follows: 
 1. Definitions. 
 1.1
“Freezone® Product” means salicylic acid corn and callus remover that is
manufactured, marketed and sold by Distributor or its Affiliates under the Freezone® trade
name, together with all modifications and improvements that may be made by Distributor to such product from time to time. 
 1.2
“Freezone® Specifications” means the Freezone® Product specifications set forth in Exhibit 1.2 to this Amendment. 
 1.3 “Original Product” means the cryosurgical wart removal product supplied by OraSure to Distributor under the Prior Agreement and originally
defined as the “Product” therein. 

 1.4 “Promo Footcare Product” means the Original Product and the Freezone® Product either singly or combined with non-medicated (containing no salicylic acid or other
pharmacologically active substance) woven “comfort pads” contained in a single package for promotional purposes. 
 1.5
“Promo Unit” means a single unit of the Promo Footcare Product, consisting of (i) one (1) Unit of the Original Product, (ii) one (1) bottle of the corn and callus remover used in the Freezone® Product, and (iii) one (1) resealable plastic bag containing twelve (12) non-medicated
( containing no salicylic acid or other pharmacologically active substance) woven “comfort pads”. 
 2. Assignment. Medtech
Holdings hereby transfers and assigns to Medtech Products all of its rights, and delegates all of the duties and obligations, under the Original Agreement as amended by this Amendment, and Medtech Products hereby accepts such rights and assumes such
duties and obligations. As a result of such transfer and assignment, Medtech Products shall be deemed to be Distributor under the Original Agreement and this Amendment. OSUR hereby consents to the foregoing assignment and assumption. 
 3. Promo Footcare Product. Subject to the terms and conditions of this Amendment and the Original Agreement, OSUR shall assemble and supply the
Promo Footcare Product to Distributor, and Distributor shall purchase the Promo Footcare Product for distribution solely in the OTC Market in the Territory. Except as provided herein and subject to the terms of this Amendment, the Promo Footcare
Product shall be deemed to be an additional Product for purposes of the Original Agreement as amended hereby. 
 4. Supply of Distributor
Components. The following shall constitute the Distributor Components for the Promo Footcare Product, which Distributor shall supply, at its sole cost, to the Assembly Contractor for use in packaging and assembling each Promo Unit purchased by
Distributor: 
  

	 	(i)	one (1) box for each Promo Unit with labeling mutually approved by OSUR and Distributor; 

  

	 	(ii)	package insert or instructions for the Original Product in form approved by OSUR; 

  

	 	(iii)	package insert or instructions for use for the Freezone® Product in form mutually approved by OSUR and Distributor, to the effect that the Freezone® Product and Original Product should not be used together; 

  

	 	(iv)	shipping case (standard corrugated); 

  

	 	(v)	shipping case label in form mutually approved by OSUR and Distributor; 

  

	 	(vi)	security detection devices (Checkpoint or SensorMatic); 

  

	 	(vii)	transparent tamper-resistant labels for box lids (if required); 

  

	 	(viii)	a bottle of the Freezone® salicylic acid corn and callus remover containing labeling which complies with Section 5 below; and 

  

	 	(ix)	twelve (12) untreated “comfort pads” contained in a resealable plastic bag. 

  

 -2- 

 Distributor shall ensure that all of the foregoing Distributor Components are manufactured, stored and
supplied in accordance with the Specifications (as defined in the Original Agreement), the Freezone® Specifications and in compliance with all applicable treaties, laws, rules and regulations within the Territory. Distributor shall supply the foregoing Distributor Components with sufficient lead times and in sufficient quantities
as directed by OSUR to permit the packaging and assembly of Promo Footcare Products purchased by Distributor and delivery to Distributor in accordance with Distributor’s Purchase Orders. 
 5. Price. Pricing for the Promo Footcare Products when produced in facilities of OSUR or the Assembly Contractor shall be as specified in Schedule
5 to this Amendment (as amended from time to time). OSUR shall have no obligation to supply the Promo Footcare Products produced in facilities of OSUR or the Assembly Contractor unless the pricing therefor is agreed to by the parties. 
 6. Labeling; Compliance with Law; Specifications. Distributor shall ensure that the Freezone® Product is manufactured, packaged and labeled in compliance with all applicable treaties, laws, rules and regulations, including all
applicable FDA or other regulatory approvals, clearances or registrations required for the manufacture, sale or distribution of the Freezone® Product. Distributor shall also ensure that all packaging and labeling provided for the Promo Footcare Product contains language
(including applicable warnings and cautionary language) required under all applicable treaties, laws, rules and regulations for the inclusion of the Freezone® Product as a component of the Promo Footcare Product, including under all applicable FDA or other regulatory approvals, clearances or
registrations. Distributor represents, warrants and agrees that the Freezone® Product
shall be manufactured in accordance with and shall comply with the specifications set forth in the Freezone® Specifications. Distributor shall be solely responsible for obtaining and maintaining, at its sole cost, all regulatory approvals, clearances or registrations, including all applicable FDA approvals, required for the
manufacture, sale or distribution of the Freezone® Product in the OTC Market. In the event
one or both of the parties is advised by the FDA or it is otherwise determined that a labeling or packaging change or a 510(k) or other regulatory approval or clearance is required in order to continue to promote, market, distribute and sell the
Promo Footcare Product in the OTC Market, Distributor shall be responsible for, and shall defend, indemnify and hold OSUR harmless from and against, all necessary out-of-pocket costs, liabilities, claims and obligations associated therewith,
including without limitation the reasonable out-of-pocket costs of OSUR’s internal personnel and the fees and expenses of its attorneys. To the extent that any costs or expenses are discretionary, no cost or expense shall be for the account of
Distributor unless specifically agreed to in writing by Distributor. 
 7. Repackaging Product. The parties acknowledge that
Distributor has previously purchased 30,000 Units of Original Product and anticipates purchasing 50,000 additional Units within the next six months, all of which it desires to repackage and reassemble into Promo Units of the Promo Footcare Product
(the “Repackaged Promo Units”). Subject to the terms of this Amendment, Distributor shall be permitted to perform the repackaging of such Original Product; provided that Distributor shall do so at its sole cost and expense and shall assume
all risk of loss for such Original Product and Repackaged Promo Units. The foregoing repackaging shall be performed solely at the facilities of the Assembly Contractor. Distributor shall not be permitted 
  

 -3- 

 to repackage any Units of Original Product except in accordance with the terms of this Section 7. Except as
expressly permitted in this Section 7, Distributor shall not be permitted to repackage or otherwise modify, alter or supplement any Original Product or Promo Footcare Product, including any labeling, packaging, product insert, warnings or
cautionary language contained therein or thereon. 
 8. Branding and Packaging. The Promo Footcare Product labeling, packaging and
package inserts shall be subject to Section 5 of the Original Agreement. The Freezone® trademark shall be considered a Distributor Trademark for all purposes hereof. No license is conferred to OSUR for the use of Freezone® except as specifically provided herein. 
 9. THE EXPRESS LIMITED WARRANTIES SET FORTH IN SECTION 7.1 OF THE PRIOR AGREEMENT SHALL NOT APPLY TO (i) THE FREEZONE® PRODUCT OR ANY LABELING, PACKAGING, PACKAGE INSERTS OR PRODUCT WARNINGS OR CAUTIONARY LANGUAGE SPECIFICALLY RELATED THERETO, OR (ii) ANY LABELING, PACKAGING, PACKAGE INSERTS OR PRODUCT WARNINGS
OR CAUTIONARY LANGUAGE REQUIRED OR INCLUDED IN OR ON A PROMO FOOTCARE PRODUCT BECAUSE OF THE INCLUSION OF THE FREEZONE® PRODUCT AS A COMPONENT THEREOF. OSUR HEREBY DISCLAIMS ANY AND ALL REPRESENATIONS, WARRANTIES AND OBLIGATIONS OF ANY KIND RELATING TO THE FOREGOING, EXPRESS OR IMPLIED, WHETHER ARISING FROM A COURSE OF
DEALING OR USAGE OF TRADE, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. 
 10. Additional Representations and Indemnification by Distributor. 
 10.1 In addition to its
representations and warranties set forth in the Original Agreement, Distributor represents and warrants to OSUR as follows: (a) no authorization, consent, approval or similar action of or by any third party (including the FDA) is required for
or in connection with Distributor’s authorization, execution, delivery or performance of this Amendment or the inclusion of the Freezone® Product as a component of the Promo Footcare Product; (b) the use of the Freezone® trademark by OSUR or Distributor will not constitute an infringement or dilution of any third party’s trademark rights in the
Territory; and (c) the manufacture, sale and use of the Freezone® Product will not
infringe upon, or constitute a misappropriation of, any third party’s intellectual property rights. 
 10.2 In addition to its
indemnification obligations set forth in the Original Agreement, Distributor shall indemnify, defend and hold harmless OSUR, its Affiliates, and the respective directors, officers, employees, agents and representatives of each of the foregoing, from
and against any and all Claims and Losses: (a) for bodily injury, personal injury, death, property damage or other injury or damage caused by or arising from, directly or indirectly, the defective design or manufacture of the
Freezone® Product, the inclusion of the Freezone® Product as a component of the Promo Footcare Product, the use by a customer of the Freezone® Product in any manner including with the Original Product, or the inadequacy, inaccuracy or
insufficiency of any product labeling or inserts (including but not limited to “CAUTION” and 
  

 -4- 

 “WARNING” labeling) in or on the Freezone® Product or which is required or included in or on the Freezone® Product or in or on the Promo Footcare Product as a result of the inclusion of the Freezone® Product as a component thereof; (b) arising out of or in connection with a material breach by Distributor of any of its
obligations hereunder, including any representations or warranties set forth herein; (c) arising out of any claim that the Freezone® trademark constitutes an infringement or dilution of a third party’s trademark rights in the Territory; or (d) arising out of a claim that any of the manufacture, marketing, import, sale or
use of the Freezone® Product infringes upon any lawful patent rights; provided, however,
that Distributor shall have no liability to OSUR for any Claims or Losses to the extent that any such Claims or Losses result from or arise out of: (i) the negligence or willful misconduct of OSUR or its Affiliates, subdistributors, employees,
agents or any person for whose action OSUR is legally liable; or (ii) a material breach by OSUR of any of its obligations under the Original Agreement or this Amendment. 
 10.3 In no event shall OSUR have any obligation or liability to Distributor, its Affiliates or any other party in connection with the
Freezone® Product or any labeling, packaging, package inserts or product warnings
associated therewith, notwithstanding any provision of the Original Agreement, except for OSUR’s limited obligation to include such items (subject to Distributor’s fulfillment of its obligation to provide Distributor Components as provided
herein and otherwise comply with this Amendment), when assembling and providing Promo Units for Distributor hereunder. 
 10.4 Any claim for
indemnification pursuant to this Section 9 shall be handled in accordance with Section 8.2.3 of the Original Agreement. 
 11.
Recalls and Complaints. Distributor shall be solely responsible for, and shall reimburse OSUR for, any costs associated with any recall, replacement or other similar action involving the Promo Footcare Product to the extent arising from the
Freezone® Product or the use thereof in any manner or any labeling or warnings related
thereto. In addition, Distributor shall have primary responsibility for investigating and responding to all complaints or adverse events or reactions related to the Freezone® Product or the use thereof. OSUR shall be solely responsible for, and shall reimburse Distributor for any “direct costs”
(as defined in Section 9.1 of the Original Agreement) associated with any recall, replacement or other similar action involving the Original Product to the extent arising solely from the Original Product or the use thereof in any manner or any
labeling or warnings related solely thereto. 
 12. Effect of Amendment. Except as amended hereby, the Original Agreement shall remain
in full force and effect. All references to the Original Agreement shall be deemed to mean the Original Agreement as amended by this Amendment. 
 13. Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania, excluding its conflict of law principles. 
 14. Counterparts. This Amendment may be executed by the parties in more than one counterpart, each of which, when executed and delivered, shall be
deemed to be an original, and all such counterparts shall constitute a single instrument. A facsimile transmission of a signed original shall have the same effect as delivery of the signed original. 
  

 -5- 

 15. Term. This Amendment shall be effective as of the first day of February, 2006 and shall remain
in effect until the last day of the fifth Contract Year of the Original Agreement or on such earlier date of termination of the Original Agreement as provided in Section 11.2 of the Original Agreement. To the extent that the Original Agreement
is subject to a Renewal Term this Amendment shall remain in full force and effect during such Renewal Term. 
 IN WITNESS WHEREOF, this
Amendment has been executed by OSUR, Medtech Holdings and Medtech Products as of the date first written above. 
  

			
	ORASURE TECHNOLOGIES, INC.
		
	By:	 	 /s/ Douglas A. Michels

	Name:	 	Douglas A. Michels
	Title:	 	President and CEO
	
	MEDTECH HOLDINGS, INC.
		
	By:	 	 /s/ Peter J. Anderson

	Name:	 	Peter Anderson
	Title:	 	Chief Financial Officer
	
	MEDTECH PRODUCTS, INC.
		
	By:	 	 /s/ Peter J. Anderson

	Name:	 	Peter Anderson
	Title:	 	Chief Financial Officer

 Guarantee 
 Prestige Brands Holdings, Inc. (“Prestige”) hereby irrevocably and unconditionally guarantees, to and for the benefit of OraSure Technologies,
Inc. (“OSUR”), the due and punctual payment in full by Medtech Products, Inc. (“Medtech Products”) of all amounts which are or may become due and payable by, and the due and punctual performance and discharge by 
  

 -6- 

 Medtech Products of all other agreements, covenants, obligations and liabilities of, Medtech Products under the
Distribution Agreement, dated as of April 24, 2003, as amended by the foregoing Amendment and as otherwise amended from time to time (the “Obligations”). In case of any failure or inability of Medtech Products duly and punctually to
perform, observe and discharge any such Obligations, Prestige hereby irrevocably and unconditionally agrees to perform, observe and discharge the same or cause the same to be performed, observed or discharged forthwith, without the requirement that
OSUR first proceed against Medtech Products for such performance. This is a present and continuing guaranty of payment and performance and not of collection, and the obligations of Prestige hereunder shall be absolute and unconditional irrespective
of the enforceability or validity of any Obligation or any other circumstance that might constitute a defense available to, or discharge of, a guarantor or surety, other than full performance. 
  

			
	Agreed To And Accepted:
	
	PRESTIGE BRANDS HOLDINGS, INC.
		
	By:	 	 /s/ Charles N. Jolly

	Name:	 	Charles N. Jolly
	Title:	 	Secretary & General Counsel
	Date:	 	February 10, 2006

  

 -7- 

 EXHIBIT 1.2 
 Freezone® Specifications 
 See attached document. 
 SCHEDULE 5

 Pricing 
 ***

 Scholle Corporation 
 2300 West Point Avenue, College Park, GA 30337 
 Phone: (404) 761-0604 Fax (404) 559-8892 
 Specifications for 5593 Mosco/Freezone 
  

			
	 Specifications:
	 	 Target:

		
	***	 	***
		
	***	 	***
		
	***	 	***
		
	***	 	***
		
	***	 	***

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00103-of-00352.parquet"}]]